Rory B Riggs - Net Worth and Insider Trading
Rory B Riggs Net Worth
The estimated net worth of Rory B Riggs is at least $53 Million dollars as of 2024-04-27. Rory B Riggs is the CEO, 10% Owner of Cibus Inc and owns about 2,727,883 shares of Cibus Inc (CBUS) stock worth over $43 Million. Rory B Riggs is the Director of Intra-Cellular Therapies Inc and owns about 76,815 shares of Intra-Cellular Therapies Inc (ITCI) stock worth over $6 Million. Rory B Riggs is also the Director of Royalty Pharma PLC and owns about 120,286 shares of Royalty Pharma PLC (RPRX) stock worth over $3 Million. Besides these, Rory B Riggs also holds FibroGen Inc (FGEN) . Details can be seen in Rory B Riggs's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Rory B Riggs has not made any transactions after 2024-01-04 and currently still holds the listed stock(s).
Transaction Summary of Rory B Riggs
Rory B Riggs Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Rory B Riggs owns 4 companies in total, including Royalty Pharma PLC (RPRX) , Intra-Cellular Therapies Inc (ITCI) , and FibroGen Inc (FGEN) among others .
Click here to see the complete history of Rory B Riggs’s form 4 insider trades.
Insider Ownership Summary of Rory B Riggs
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| RPRX | Royalty Pharma PLC | 2024-01-04 | director |
| ITCI | Intra-Cellular Therapies Inc | 2022-03-18 | director |
| FGEN | FibroGen Inc | 2018-03-13 | director |
| CBUS | Cibus Inc | 2023-12-12 | director & Chief Executive Officer |
Rory B Riggs Latest Holdings Summary
Rory B Riggs currently owns a total of 4 stocks. Among these stocks, Rory B Riggs owns 2,727,883 shares of Cibus Inc (CBUS) as of December 12, 2023, with a value of $43 Million and a weighting of 81.18%. Rory B Riggs owns 76,815 shares of Intra-Cellular Therapies Inc (ITCI) as of March 18, 2022, with a value of $6 Million and a weighting of 10.57%. Rory B Riggs also owns 120,286 shares of Royalty Pharma PLC (RPRX) as of January 4, 2024, with a value of $3 Million and a weighting of 6.33%. The other 1 stocks FibroGen Inc (FGEN) have a combined weighting of 1.92% among all his current holdings.
Latest Holdings of Rory B Riggs
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CBUS | Cibus Inc | 2023-12-12 | 2,727,883 | 15.84 | 43,209,667 |
| ITCI | Intra-Cellular Therapies Inc | 2022-03-18 | 76,815 | 73.26 | 5,627,467 |
| RPRX | Royalty Pharma PLC | 2024-01-04 | 120,286 | 28.00 | 3,368,008 |
| FGEN | FibroGen Inc | 2018-03-13 | 984,913 | 1.04 | 1,024,310 |
Holding Weightings of Rory B Riggs
Rory B Riggs Form 4 Trading Tracker
According to the SEC Form 4 filings, Rory B Riggs has made a total of 1 transactions in Cibus Inc (CBUS) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Cibus Inc is the acquisition of 517,107 shares on December 12, 2023, which cost Rory B Riggs around $5 Million.
According to the SEC Form 4 filings, Rory B Riggs has made a total of 1 transactions in Intra-Cellular Therapies Inc (ITCI) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Intra-Cellular Therapies Inc is the sale of 226,670 shares on March 18, 2022, which brought Rory B Riggs around $14 Million.
According to the SEC Form 4 filings, Rory B Riggs has made a total of 18 transactions in Royalty Pharma PLC (RPRX) over the past 5 years, including 1 buys and 17 sells. The most-recent trade in Royalty Pharma PLC is the sale of 470,000 shares on January 4, 2024, which brought Rory B Riggs around $13 Million.
More details on Rory B Riggs's insider transactions can be found in the Insider Trading History of Rory B Riggs table.Insider Trading History of Rory B Riggs
- 1
Rory B Riggs Trading Performance
GuruFocus tracks the stock performance after each of Rory B Riggs's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Rory B Riggs is 21.49%. GuruFocus also compares Rory B Riggs's trading performance to market benchmark return within the same time period. The performance of stocks bought by Rory B Riggs within 3 months outperforms 2 times out of 4 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Rory B Riggs's insider trading performs compared to the benchmark.
Performance of Rory B Riggs
Average Return
-10.87%
Outperforming Transactions
33%
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 19 | 21.49 | -2.55 | -10.87 | 22.46 | 2.06 |
| Relative Return to S&P 500(%) | 13.94 | 15.4 | -12.67 | -25.69 | 15.02 | -9.09 |
Rory B Riggs Ownership Network
Ownership Network List of Rory B Riggs
Ownership Network Relation of Rory B Riggs
Rory B Riggs Owned Company Details
What does Royalty Pharma PLC do?
Who are the key executives at Royalty Pharma PLC?
Rory B Riggs is the director of Royalty Pharma PLC. Other key executives at Royalty Pharma PLC include 10 percent owner Avara Management Ltd , EVP & CFO Terrance P. Coyne , and director & CEO & Chairman of the Board Pablo G. Legorreta .
Royalty Pharma PLC (RPRX) Insider Trades Summary
Over the past 18 months, Rory B Riggs made 4 insider transaction in Royalty Pharma PLC (RPRX) with a net sale of 2,479,950. Other recent insider transactions involving Royalty Pharma PLC (RPRX) include a net sale of 420,000 shares made by George W. Lloyd , a net purchase of 600,000 shares made by Pablo G. Legorreta , and a net sale of 180,000 shares made by Terrance P. Coyne .
In summary, during the past 3 months, insiders sold 0 shares of Royalty Pharma PLC (RPRX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 4,484,548 shares of Royalty Pharma PLC (RPRX) were sold and 600,000 shares were bought by its insiders, resulting in a net sale of 3,884,548 shares.
Royalty Pharma PLC (RPRX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Royalty Pharma PLC Insider Transactions
Rory B Riggs Mailing Address
Above is the net worth, insider trading, and ownership report for Rory B Riggs. You might contact Rory B Riggs via mailing address: 65 Railroad Ave, Ridgefield Nj 07657.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
